WASHINGTON, April 18, 2018 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association(PCMA) will hold its annual "PBM Policy Forum" tomorrow, April 19, at the Newseum in Washington, D.C. This year's event features subject matter experts explaining key issues in the drug supply chain at the federal and state levels. PBMs reduce drug costs by 30 percent for more than 266 million Americans enrolled in private and public plans, most notably Medicare Part D.
Kim Gwiazdzinski, Senior Director, Trade Relations, Value and Outcomes Contracting, Prime Therapeutics
Employers' Perspective on the Value of PBMs
Kevin Host, President and Chief Operating Officer, PSG Consulting
PCMA is the national association representing America's pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, Medicaid plans, and others.